<VariationArchive RecordType="classified" VariationID="625617" VariationName="GRCh37/hg19 20q13.32(chr20:57244540-57246216)" VariationType="copy number loss" Accession="VCV000625617" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-04-21" MostRecentSubmission="2019-04-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="613921" VariationID="625617">
      <GeneList>
        <Gene Symbol="STX16" FullName="syntaxin 16" GeneID="8675" HGNC_ID="HGNC:11431" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="58651283" stop="58679526" display_start="58651283" display_stop="58679526" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="57226308" stop="57254581" display_start="57226308" display_stop="57254581" Strand="+" />
          </Location>
          <OMIM>603666</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 20q13.32(chr20:57244540-57246216)</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>20q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" innerStart="57244540" innerStop="57246216" display_start="57244540" display_stop="57246216" variantLength="1677" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.(?_57244540)_(57246216_?)del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.(?_57244540)_(57246216_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 20q13.32(chr20:57244540-57246216) AND Pseudohypoparathyroidism type 1B" Accession="RCV000767625" Version="1">
        <ClassifiedConditionList TraitSetID="321">
          <ClassifiedCondition DB="MedGen" ID="C1864100">Pseudohypoparathyroidism type 1B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-04-21" MostRecentSubmission="2019-04-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="321" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4057" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PHP IB</ElementValue>
                <XRef Type="MIM" ID="603233" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudohypoparathyroidism type 1B</ElementValue>
                <XRef ID="Pseudohypoparathyroidism+type+1B/6036" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011301" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudohypoparathyroidism Type IB</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHP1B</ElementValue>
                <XRef Type="MIM" ID="603233" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of GNAS inactivation include the phenotypes pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). PHP-Ia and PHP-Ic are characterized by: End-organ resistance to endocrine hormones including parathyroid hormone (PTH), thyroid-stimulating hormone (TSH), gonadotropins (LH and FSH), growth hormone-releasing hormone (GHRH), and CNS neurotransmitters (leading to obesity and variable degrees of intellectual disability and developmental delay); and The Albright hereditary osteodystrophy (AHO) phenotype (short stature, round facies, and subcutaneous ossifications) and brachydactyly type E (shortening mainly of the 4th and/or 5th metacarpals and metatarsals and distal phalanx of the thumb). Although PHP-Ib is characterized principally by PTH resistance, some individuals also have partial TSH resistance and mild features of AHO (e.g., brachydactyly). PPHP, a more limited form of PHP-Ia, is characterized by various manifestations of the AHO phenotype without the hormone resistance or obesity. POH and OC are even more restricted variants of PPHP: POH consists of dermal ossification beginning in infancy, followed by increasing and extensive bone formation in deep muscle and fascia. OC consists of extra-skeletal ossification that is limited to the dermis and subcutaneous tissues.</Attribute>
                <XRef ID="NBK459117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10680" />
                <XRef ID="10680" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29072892</ID>
                <ID Source="BookShelf">NBK459117</ID>
              </Citation>
              <XRef ID="94089" DB="Orphanet" />
              <XRef ID="C1864100" DB="MedGen" />
              <XRef ID="MONDO:0011301" DB="MONDO" />
              <XRef Type="MIM" ID="603233" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1761530" SubmissionDate="2019-04-01" DateLastUpdated="2019-04-21" DateCreated="2019-04-21">
        <ClinVarSubmissionID localKey="ES165|OMIM:603233" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000898247" DateUpdated="2019-04-21" DateCreated="2019-04-21" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG CNV Guidelines, 2011</Attribute>
          <Citation>
            <ID Source="PubMed">21681106</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" innerStart="57244540" innerStop="57246216" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="603233" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5380435</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1761530" TraitType="Disease" MappingType="XRef" MappingValue="603233" MappingRef="OMIM">
        <MedGen CUI="C1864100" Name="Pseudohypoparathyroidism type 1B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

